At Intalytics, a Kalibrate company, we believe our success is driven as much by our people as our technology. In our ongoing meet the team series, we’re showcasing some of the talent and expertise within the Intalytics family. This article features our Managing Director, Matt Montgomery.
In my current role, I lead Intalytics’ sales efforts in support of both prospective and existing clients.
The only consistent theme each day is that I have an opportunity to discuss how predictive analytics can inform decision-making for firms seeking location-centric insights. Outside of that, there is no “typical” associated with my role – each day is unique in terms of the industries discussed, the business questions and challenges posed by tenants and investors, the datasets relevant to potential solutions, the custom architecture of the solutions designed to meet client-specific needs.
Three aspects of my current role stand out in my mind – the ability to work with and learn from some of the best and brightest in this industry, the opportunity to engage in problem-solving with leading operators and investment firms, and the consultative nature of my work.
I had already spent a decade working in the consumer analytics industry and had developed a passion for the space. While working for a healthcare technology firm in 2015, I was approached with an opportunity to return to this industry and build out the sales and marketing functions at Intalytics.
As I learned more about the background of the firm through discussions with company leadership, it became clear that I had a fantastic opportunity to join and learn from a team of subject matter experts in the predictive analytics industry while designing and implementing a strategy to accelerate the growth of Intalytics. It was the easiest decision of my professional career.
The healthcare industry remains quite fragmented, presenting both a challenge and an opportunity to investors and operators alike. Providers in the medical, dental, and veterinary sectors are working to achieve meaningful scale, with brick-and-mortar growth strategies that run the gamut – those focused on acquisitions, those oriented to organic expansion via de novo development, and those that employ a hybridized strategy that effectively combines these two approaches.
We have considerable experience providing our healthcare clients with bespoke, data-driven solutions, irrespective of the strategy that they employ.
General themes that I think will be relevant near-term include:
- Continued push to “roll up” and achieve scale, particularly in the dental and veterinary sectors
- A greater desire amongst medical and dental providers to understand what we think of as “omnichannel” impacts to performance – specifically, how virtual care will impact real estate decision-making for specific service lines or specialties